The Stochastic Oscillator for GEVO moved into overbought territory on November 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
GEVO broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GEVO entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GEVO's RSI Indicator exited the oversold zone, 28 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on GEVO as a result. In 74 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for GEVO just turned positive on October 27, 2026. Looking at past instances where GEVO's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.
GEVO moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEVO advanced for three days, in 186 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.258) is normal, around the industry mean (2.284). P/E Ratio (-1.544) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.012) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. GEVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
GPRE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where GPRE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +0.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where GPRE advanced for three days, in 206 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GPRE as a result. In 74 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for GPRE turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
GPRE moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for GPRE moved below the 200-day moving average on October 20, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GPRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for GPRE entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. GPRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.066) is normal, around the industry mean (1.147). P/E Ratio (7.075) is within average values for comparable stocks, (3.243). Projected Growth (PEG Ratio) (5.870) is also within normal values, averaging (3.769). Dividend Yield (0.036) settles around the average of (0.195) among similar stocks. P/S Ratio (0.634) is also within normal values, averaging (0.578).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GPRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
GEVO | GPRE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 38 Fair valued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 55 | |
PRICE GROWTH RATING 1..100 | 60 | 61 | |
P/E GROWTH RATING 1..100 | 23 | 74 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GEVO's Valuation (38) in the Chemicals Specialty industry is somewhat better than the same rating for GPRE (85). This means that GEVO’s stock grew somewhat faster than GPRE’s over the last 12 months.
GEVO's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as GPRE (100). This means that GEVO’s stock grew similarly to GPRE’s over the last 12 months.
GPRE's SMR Rating (55) in the Chemicals Specialty industry is somewhat better than the same rating for GEVO (98). This means that GPRE’s stock grew somewhat faster than GEVO’s over the last 12 months.
GEVO's Price Growth Rating (60) in the Chemicals Specialty industry is in the same range as GPRE (61). This means that GEVO’s stock grew similarly to GPRE’s over the last 12 months.
GEVO's P/E Growth Rating (23) in the Chemicals Specialty industry is somewhat better than the same rating for GPRE (74). This means that GEVO’s stock grew somewhat faster than GPRE’s over the last 12 months.
| GEVO | GPRE | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 85% | N/A |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 80% |
| Momentum ODDS (%) | 3 days ago 80% | 3 days ago 78% |
| MACD ODDS (%) | 3 days ago 81% | 3 days ago 82% |
| TrendWeek ODDS (%) | 3 days ago 82% | 3 days ago 83% |
| TrendMonth ODDS (%) | 3 days ago 79% | 3 days ago 84% |
| Advances ODDS (%) | 5 days ago 84% | 14 days ago 74% |
| Declines ODDS (%) | 28 days ago 83% | 18 days ago 83% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 86% |
| Aroon ODDS (%) | 3 days ago 89% | 3 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEVO’s FA Score shows that 1 FA rating(s) are green while GPRE’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GEVO’s TA Score shows that 5 TA indicator(s) are bullish while GPRE’s TA Score has 3 bullish TA indicator(s).
GEVO (@Chemicals: Specialty) experienced а +11.20% price change this week, while GPRE (@Chemicals: Major Diversified) price change was -6.17% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -2.51%. For the same industry, the average monthly price growth was -4.65%, and the average quarterly price growth was -10.56%.
The average weekly price growth across all stocks in the @Chemicals: Major Diversified industry was -4.13%. For the same industry, the average monthly price growth was -3.13%, and the average quarterly price growth was -24.18%.
GEVO is expected to report earnings on Nov 10, 2026.
GPRE is expected to report earnings on Feb 05, 2027.
The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
@Chemicals: Major Diversified (-4.13% weekly)The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.
A.I.dvisor indicates that over the last year, GEVO has been loosely correlated with ASPI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GEVO jumps, then ASPI could also see price increases.
| Ticker / NAME | Correlation To GEVO | 1D Price Change % | ||
|---|---|---|---|---|
| GEVO | 100% | +13.93% | ||
| ASPI - GEVO | 38% Loosely correlated | +20.64% | ||
| RPC - GEVO | 38% Loosely correlated | -0.82% | ||
| AMTX - GEVO | 37% Loosely correlated | -6.36% | ||
| SSL - GEVO | 28% Poorly correlated | -2.37% | ||
| GPRE - GEVO | 28% Poorly correlated | -3.43% | ||
More | ||||
A.I.dvisor indicates that over the last year, GPRE has been loosely correlated with REX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if GPRE jumps, then REX could also see price increases.
| Ticker / NAME | Correlation To GPRE | 1D Price Change % | ||
|---|---|---|---|---|
| GPRE | 100% | -3.43% | ||
| REX - GPRE | 59% Loosely correlated | +0.51% | ||
| ALB - GPRE | 42% Loosely correlated | +0.89% | ||
| LYB - GPRE | 41% Loosely correlated | -1.48% | ||
| DD - GPRE | 41% Loosely correlated | +1.10% | ||
| CC - GPRE | 39% Loosely correlated | N/A | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLAX | 32.37 | 0.56 | +1.76% |
| Franklin FTSE Asia ex Japan ETF (FLAX) | |||
| PYPG | 8.57 | 0.11 | +1.25% |
| Leverage Shares 2X Long PYPL Daily ETF (PYPG) | |||
| BSV | 76.98 | -0.08 | -0.10% |
| Vanguard Short-Term Bond ETF (BSV) | |||
| NBIE | 26.15 | -0.16 | -0.61% |
| Neuberger International Core Equity ETF (NBIE) | |||
| SCO | 18.77 | -0.42 | -2.19% |
| ProShares UltraShort Bloomberg Crude Oil (SCO) | |||